Related Experiment Video
Updated: Jul 4, 2026
09:57
Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Chemokines in atherosclerosis: an update.
Alma Zernecke1, Erdenechimeg Shagdarsuren, Christian Weber
1Institute for Molecular Cardiovascular Research, University Hospital, RWTH Aachen University, Germany.
Arteriosclerosis, Thrombosis, and Vascular Biology
|June 21, 2008
Summary
Chemokines are crucial in atherosclerosis, influencing plaque development and stability. Recent research clarifies how specific chemokines and their receptors regulate cell recruitment and immune balance, paving the way for targeted therapies.
Area of Science:
- Cardiovascular Research
- Immunology
- Molecular Biology
Background:
- Chemokines are vital in atherogenesis, plaque progression, and destabilization.
- Understanding chemokine regulation and function in atherosclerosis is continually evolving.
Purpose of the Study:
- To update recent developments in chemokine research related to atherosclerosis.
- To highlight specific chemokines, receptors, and their roles in plaque formation and immune response.
Main Methods:
- Review of recent advancements in understanding chemokine regulation.
- Analysis of specific chemokine/receptor pairs (CCL5/CCR1/CCR5, CXCL10/CXCR3, CX3CL1/CX3CR1, CXCL16/CXCR6, CXCL1/CXCR2, CXCL12/CXCR4).
- Discussion of the role of Macrophage Migration Inhibitory Factor (MIF).
Main Results:
- Identification of regulators for the pro-atherogenic chemokine CCL5 transcription.
- Defined distinct roles for CCR1 and CCR5 in plaque formation and immune balance.
- Elucidated differential effects of T cell-activating chemokines (e.g., CXCL10/CXCR3) based on site and stage.
- Discussed transmembrane chemokines (CX3CL1, CXCL16) in cell recruitment and shear-mediated modulation.
- Analyzed CXCR2, CXCR4, CXCL1, CXCL12, and MIF in atheroprogression.
Conclusions:
- Significant progress has been made in understanding chemokine complexity in atherosclerosis.
- Further advances are anticipated, enabling targeted interventions for prevention and therapy.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:38Inflammation
Overview
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...